Autopsy report · NCT01210365
Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema
Cause of deathOther
“EF decided suspended the study because the investigational product was changed.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 2 years 2 months before it stopped.
- 27 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Eurofarma Laboratorios S.A.
- Sponsor type
- Industry
- Conditions
- Congestive Heart Failure
- Interventions
- Diurisa®; Lasix ®
- Participants
- 27
- Sites
- 4
- Countries
- Brazil
Trials that died the same way
- Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
“The study terminated early because the company was longer providing the investigational product.” - A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
“The study was suspended by the IRB of record and subsequently terminated” - Liver Transplantation With Tregs at UCSF
“The study was terminated by the Sponsor prior to any participants receiving the investigational product.” - Reducing Frailty for Older Cancer Survivors Using Supplements II
“The study has been suspended by the IRB pending review of a study-related issue” - Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
“The study was terminated due to administrative, non-safety related reasons.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.